Benign myoclonic epilepsy of infancy evolving to Jeavons syndrome

Fettouma Moutaouakil1, Hicham El Otmani, Hicham Fadel

  • 1Department of Neurology, Al Kortobi Hospital, Tangier, Morocco. mfettouma@hotmail.com

Pediatric Neurology
|August 10, 2010
PubMed

Insights

Benign myoclonic epilepsy of infancy can evolve into Jeavons syndrome, characterized by eyelid myoclonia and absences. This case highlights the need for extended monitoring in infants diagnosed with benign myoclonic epilepsy.

Area of Science:

  • Neurology
  • Epileptology

Background:

  • Benign myoclonic epilepsy of infancy (BMEI) is a rare epileptic syndrome typically associated with a favorable prognosis.
  • Recent evidence suggests BMEI may have less favorable outcomes than previously presumed.

Observation:

  • A 14-year-old male with a history of infantile myoclonic seizures, diagnosed as BMEI, developed photosensitive eyelid myoclonia with absences (Jeavons syndrome) at age 10.
  • The patient's initial infantile seizures were managed with valproate, and later eyelid myoclonia with absences was successfully treated with lamotrigine.

Findings:

  • This case presents the second documented instance of BMEI evolving into Jeavons syndrome.
  • The evolution suggests a potential continuum between these myoclonic epileptic syndromes.

Implications:

  • Longer-term neurodevelopmental and seizure monitoring is crucial for patients diagnosed with BMEI.
  • A common underlying genetic etiology may link BMEI and Jeavons syndrome, warranting further investigation.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...